Skip to main content
Top
Published in: Clinical Rheumatology 1/2013

01-03-2013 | Case Report

Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus

Authors: Liza Rajasekhar, Shabina Habibi, Pushpalatha Sudhakar, Narsimulu Gumdal

Published in: Clinical Rheumatology | Special Issue 1/2013

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a multisystem disease of autoimmune origin. Lymphedema is a very uncommon entity and has not been previously documented in SLE. We report lymphatic obstruction involving all four limbs as a cause of extremity edema in a patient with SLE.
Literature
1.
go back to reference Gunaydin I et al (1999) Lower limb pitting edema in systemic lupus erythematosus. Rheumatol Int 18(4):159–160PubMedCrossRef Gunaydin I et al (1999) Lower limb pitting edema in systemic lupus erythematosus. Rheumatol Int 18(4):159–160PubMedCrossRef
2.
go back to reference Pittau E et al (1998) Systemic lupus erythematosus with pitting oedema of the distal lower limbs. Br J Rheumatol 37(1):104–105PubMedCrossRef Pittau E et al (1998) Systemic lupus erythematosus with pitting oedema of the distal lower limbs. Br J Rheumatol 37(1):104–105PubMedCrossRef
3.
go back to reference Pittau E, Passiu G, Mathieu A (2000) Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging. Joint Bone Spine 67(6):544–549PubMedCrossRef Pittau E, Passiu G, Mathieu A (2000) Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging. Joint Bone Spine 67(6):544–549PubMedCrossRef
4.
go back to reference Yamanishi Y et al (1993) Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome). Ryumachi 33(2):162–168PubMed Yamanishi Y et al (1993) Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome). Ryumachi 33(2):162–168PubMed
5.
go back to reference Alpigiani MG et al (2008) Remitting symmetrical pitting edema of hands and feet at onset of pediatric systemic lupus erythematosus: a case report. Clin Exp Rheumatol 26(6):1166PubMed Alpigiani MG et al (2008) Remitting symmetrical pitting edema of hands and feet at onset of pediatric systemic lupus erythematosus: a case report. Clin Exp Rheumatol 26(6):1166PubMed
6.
go back to reference Kiely PD, Mortimer PS, Bourke BE (1996) Lymphatic function in inflammatory arthritis. Br J Rheumatol 35(4):396PubMedCrossRef Kiely PD, Mortimer PS, Bourke BE (1996) Lymphatic function in inflammatory arthritis. Br J Rheumatol 35(4):396PubMedCrossRef
7.
go back to reference McRorie ER et al (1995) Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol 34(7):689–691PubMedCrossRef McRorie ER et al (1995) Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol 34(7):689–691PubMedCrossRef
Metadata
Title
Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus
Authors
Liza Rajasekhar
Shabina Habibi
Pushpalatha Sudhakar
Narsimulu Gumdal
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue Special Issue 1/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1268-y

Other articles of this Special Issue 1/2013

Clinical Rheumatology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine